Lactobacilli-Derived Microbe-Associated Molecular Patterns (MAMPs) in Host Immune Modulation
Biomolecules · 17.11.2025 · 15 (11) · 1609
DOI: 10.3390/biom15111609 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 17.11.2025. Verfasst von Salvatore Furnari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95123 Catania, Italy. Hauptthemen laut MEDLINE: Lactobacillus, Immunomodulation, Pathogen-Associated Molecular Pattern Molecules. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 318 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU - PNRR Project "HEAL-ITALIA", European Union—NextGenerationEU.
Abstract (Originalsprache)
Although traditionally sidelined by live probiotic effects, Lactobacilli-derived Microbe-Associated Molecular Patterns (MAMPs) are emerging as potent modulators of innate and adaptive immune responses, capable of acting independently of bacterial viability. However, the underlying mechanisms remain incompletely understood. These MAMPs, such as peptidoglycan (PGN), lipoteichoic acid (LTA), and exopolysaccharides (EPSs), interact with pattern recognition receptors (PRRs) like Toll-like receptors (TLRs), initiating immune-signaling cascades that regulate cytokine production and inflammation. Lactobacilli-derived MAMPs exhibit dual immunomodulatory effects: they can enhance pro-inflammatory responses, e.g., interleukin-1β (IL-1β), IL-6, and tumor necrosis factor alpha (TNF-α) under inflammatory contexts, while enhancing regulatory pathways via IL-10 and regulatory T-cell (Tregs) induction in anti-inflammatory settings. Importantly, these immunomodulatory properties persist in the absence of bacterial viability, making MAMPs promising candidates for postbiotic therapies. This opens new avenues for MAMP-based strategies to target inflammation, overcoming the risks associated with live bacterial administration. This review examines the therapeutic relevance of non-viable MAMPs, particularly in inflammatory diseases where they have demonstrated benefits in reducing tissue damage, enhancing gut barrier function, and alleviating disease symptoms. Additionally, we discuss regulatory and translational challenges hindering their clinical implementation, highlighting the need for standardized characterization, a clear safety framework, and strain-specific profiling. Given their ability to fine-tune immune responses, MAMPs represent an emerging strategy for innovative treatments aimed at restoring immune balance and reinforcing host–microbe interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95123 Catania, Italy.
ORCID-Profile: Salvatore Furnari, Adriana Garozzo, Pio Maria Furneri, Virginia Fuochi
Förderung
- NextGenerationEU - PNRR Project "HEAL-ITALIA"
- European Union—NextGenerationEU
Zitieren
APA
Furnari, S., Ciantia, R., Garozzo, A., Furneri, P. M., & Fuochi, V. (2025). Lactobacilli-Derived Microbe-Associated Molecular Patterns (MAMPs) in Host Immune Modulation. Biomolecules, 15(11), 1609. https://doi.org/10.3390/biom15111609
Vancouver
Furnari S, Ciantia R, Garozzo A, Furneri PM, Fuochi V. Lactobacilli-Derived Microbe-Associated Molecular Patterns (MAMPs) in Host Immune Modulation. Biomolecules. 2025;15(11):1609. doi:10.3390/biom15111609
BibTeX
@article{Furnari2025,
author = {Furnari, Salvatore and Ciantia, Ruben and Garozzo, Adriana and Furneri, Pio Maria and Fuochi, Virginia},
title = {Lactobacilli-Derived Microbe-Associated Molecular Patterns (MAMPs) in Host Immune Modulation},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {11},
pages = {1609},
doi = {10.3390/biom15111609}
}
EUVIMED